Fundamental Data for LIFC

LifeCell Corporation develops and markets biologic products for the repair or replacement of damaged or inadequate tissues. The company''s core preservation technology produces an acellular tissue matrix, which retains the essential biochemical and structural components necessary for normal tissue regeneration. The company''s product development programs include a small diameter vascular graft as an alternative to autografted blood vessels, orthopedic applications of its acellular dermal matrix and Thrombosol, a formulation for storage of platelets. (PRESS RELEASE)

# Employees: 443

Address: One Millennium Way,Branchburg,NJ,USA

Phone: 908 947-1100

Fax: 908-947-1101

Website: www.lifecell.com

Email:

Sector: Medical

Industry: MED-BIOMED/GENE

Executive Officers

Lisa N. Colleran (Sr. V.P.; Commercial. Oper.)

Bruce Lamb Ph.D. (Sr. V.P.; Devlpt.; Regulatory Affairs & Quality)

Steven T. Sobieski (V.P.; Fin. & Admn.; C.F.O)

Bradly C. Tyler (Contrl.; Prin. Acctg. Off.)

Paul G. Thomas (Chmn.; Pres.; C.E.O.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 3/31/2008

Next Earnings Date(Expected): 7/23/2008

Mean EPS (Next Qtr): $0.25

Mean EPS (Year): $1.00

Mean Estimate(Long Term): ($0.01)

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 2

Shares Performance

Period	LIFC	Compare to S&P
YTD	-0.01 %	-0.01 %
4 Weeks	-0.01 %	-0.01 %
12 Weeks	-0.01 %	-0.01 %

Shares Information

Analyst Coverage: Y

Avg Volume: 729501

Shares Outstanding: 34M

Market Cap: ($0.01)M

52 Week High: $51.05

52 Week Low: ($0.01)

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 1/1/1990 LIFC split by factor of 1.500

Earnings Performance

EPS Growth in Last Quarter: 0.00 %

EPS Growth in Last Year: 0.00 %

Sales Growth in Last Quarter: 3.48 %

Sales Growth in Last Quarter: 26.69 %

Financials

Qtr Book Value: ($0.01)

Cash Flow/Share: ($0.01)

Change in Payout Ratio: 0.000

Price/Sales: -0.010